StonvexLoading…
StonvexStonvexStonvexCore line items from REAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $1.97B | $1.26B | $689.16M |
Operating Income | $-9.25M | $-25.23M | $-26.01M |
Net Income | $-8.11M | $-26.54M | $-27.50M |
EPS (Diluted) | $-0.04 | $-0.14 | $-0.15 |
Total Assets | $126.86M | $86.59M | $64.55M |
Total Liabilities | $75.28M | $54.45M | $27.46M |
Cash & Equivalents | $33.21M | $23.38M | $14.71M |
Free Cash Flow OCF − CapEx | $64.83M | $47.69M | $18.35M |
Shares Outstanding | 210.48M | 202.50M | 183.43M |